Tenaya Therapeutics, Inc.
TNYA
$2.13
$0.115.24%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | -17.89% | -25.78% | -30.50% | -18.75% | -5.25% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -21.87% | -18.43% | -21.61% | -13.61% | -12.20% |
Operating Income | 21.87% | 18.43% | 21.61% | 13.61% | 12.20% |
Income Before Tax | 20.89% | 16.64% | 20.37% | 12.04% | 11.54% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 20.89% | 16.64% | 20.37% | 12.04% | 11.54% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 20.89% | 16.64% | 20.37% | 12.04% | 11.54% |
EBIT | 21.87% | 18.43% | 21.61% | 13.61% | 12.20% |
EBITDA | 23.35% | 21.29% | 22.90% | 14.37% | 12.79% |
EPS Basic | 58.36% | 38.57% | 31.71% | 24.53% | 24.24% |
Normalized Basic EPS | 58.34% | 38.56% | 31.72% | 24.55% | 24.25% |
EPS Diluted | 58.36% | 38.57% | 31.71% | 23.90% | 24.24% |
Normalized Diluted EPS | 58.34% | 38.56% | 31.72% | 24.55% | 24.25% |
Average Basic Shares Outstanding | 89.94% | 35.67% | 16.61% | 16.55% | 16.77% |
Average Diluted Shares Outstanding | 89.94% | 35.67% | 16.61% | 16.55% | 16.77% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |